SciELO - Scientific Electronic Library Online

 
vol.69 número3Metaanálisis sobre los factores pronóstico relacionados con la mortalidad en niños con leucemia linfoblástica agudaFactores pronósticos de supervivencia en pacientes pediátricos con leucemia linfoblástica aguda afiliados al Seguro Popular índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Boletín médico del Hospital Infantil de México

versión impresa ISSN 1665-1146

Resumen

DORANTES-ACOSTA, Elisa et al. Comparison, in relation to outcome, of the clinical characteristics at diagnosis of children with acute lymphoblastic leukemia affiliated with the Seguro Popular insurance program. Bol. Med. Hosp. Infant. Mex. [online]. 2012, vol.69, n.3, pp.190-196. ISSN 1665-1146.

Background. Acute lymphoblastic leukemia (ALL) is the most common cancer in childhood. Patients are classified according to clinical, biological, and molecular characteristics as well as their response to initial therapy. The objective of this study is aimed to characterize the diagnostic findings in a sample of Mexican patients with ALL and to identify clinical differences according to crude mortality. Methods. We reviewed clinical records of 391 pediatric ALL patients in nine hospitals in Mexico affiliated with the Seguro Popular insurance program. Results. Included in this study were 296 living patients and 95 deceased patients. Mean age was 6.48 years and 8.31 years for living and deceased patients, respectively. Signs and symptoms associated with seeking medical care were fever, pallor, fatigue and weakness. The main hematologic abnormalities were anemia and thrombocytopenia. The largest proportion of blasts in peripheral blood was observed in the group of deceased patients; 86.4% of the sample had immunophenotype in the clinical record and only 11.2% had cytogenetic study. One hundred forty eight patients were classified as standard risk and 230 patients as high risk. Conclusions. To characterize the population of children with ALL allows health systems to be aware of the features of patients with ALL and to implement specific actions and to develop strategies so that all patients have access to immunophenotype and cytogenetic studies.

Palabras llave : acute lymphoblastic leukemia; children; clinical features; Mexico.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons